The mechanism of a human reaction to vibration stress by palmar sweating in relation to autonomic nerve tone.
OBJECTIVE
To clarify the mechanism of a human reaction to vibration stress by palmar sweating in relation to the autonomic nerve tone.


METHODS
The autonomic nerve tone was divided into four types by using digital photoelectroplethysmography (PTG) with auditory stimuli: normal (N), hyperreactive (I and D), and hyporeactive (P) types. Palmar sweating and digital PTG were simultaneously measured on the right palm and middle finger, respectively, in 20 healthy men. The left hand gripping the handle with a grasp strength of 49 N was exposed to vibration at a frequency of 125 Hz and acceleration magnitudes of 0 m/s2 (as a control), 30 m/s2, or 50 m/s2 for 3 min. The volume of palmar sweating was recorded before, during, and 30 min after vibration load. Three kinds of drugs related to the autonomic nervous system were orally administered to the subjects. Then 80 min after administration, the experiments were repeated.


RESULTS
Of 20 subjects, 17 showed normal autonomic nerve tone (N type), and 3 hyperreactive (I type). The palmar sweating reaction to vibration in I-type subjects was greater and lasted longer than that in N-type subjects. Vibration with an acceleration of 50 m/s2 produced the greatest reaction which was about 7 times larger than that at 0 m/s2 and 2.5 times that at 30 m/s2 (P < 0.01). Sulpiride decreased palmar sweating during vibration, while prazosin and scopolamine inhibited it.


CONCLUSIONS
The palmar sweating reaction to vibration stress was related to the background level of the autonomic nerve tone. The sweating volume was in direct proportion to the acceleration magnitude of vibration. The reaction of palmar sweating to vibration stress may be mediated through both the adrenergic and cholinergic fibers of the autonomic nervous system.
Ando
H
H
Department of Environmental Medicine, Kurume University School of Medicine, Japan. hando@med.kurume-u.ac.jp
Ishitake
T
T
Miyazaki
Y
Y
Kano
M
M
Tsutsumi
A
A
Matoba
T
T
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects / Q000502:physiology*; D006225:Hand / Q000502:physiology*; D006801:Humans; D008297:Male; D010991:Plethysmography; D011224:Prazosin / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D013312:Stress, Physiological / Q000503:physiopathology; D013469:Sulpiride / Q000494:pharmacology; D013546:Sweating / Q000187:drug effects / Q000502:physiology*; D014732:Vibration
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D013469:Sulpiride; D012601:Scopolamine; D011224:Prazosin